TET2 c.1432G>T ;(p.E478*)

Variant ID: 4-106156531-G-T

NM_001127208.2(TET2):c.1432G>T;(p.E478*)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Comprehensive and unbiased multiparameter high-throughput screening by compaRe finds effective and subtle drug responses in AML models.

Elife
Chalabi Hajkarim, Morteza M; Karjalainen, Ella E; Osipovitch, Mikhail M; Dimopoulos, Konstantinos K; Gordon, Sandra L SL; Ambri, Francesca F; Rasmussen, Kasper Dindler KD; Grønbæk, Kirsten K; Helin, Kristian K; Wennerberg, Krister K; Won, Kyoung-Jae KJ
Publication Date: 2022-02-15

Variant appearance in text: TET2: 1432G>T; Glu478*
PubMed Link: 35166670
Variant Present in the following documents:
  • elife-73760-supp3.xlsx, sheet 1
View BVdb publication page



Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients.

Nature Communications
Zhang, Yongliang Y; Yao, Yu Y; Xu, Yaping Y; Li, Lifeng L; Gong, Yan Y; Zhang, Kai K; Zhang, Meng M; Guan, Yanfang Y; Chang, Lianpeng L; Xia, Xuefeng X; Li, Lin L; Jia, Shuqin S; Zeng, Qiang Q
Publication Date: 2021-01-04

Variant appearance in text: TET2: 1432G>T; E478*
PubMed Link: 33397889
Variant Present in the following documents:
  • 41467_2020_20162_MOESM6_ESM.xlsx, sheet 1
View BVdb publication page